Effects of Different Treatment Methods Applied to Spine in Chronic Non-Spesific Low Back Pain

November 24, 2022 updated by: Erkan Erol, Tokat Gaziosmanpasa University

Effects of Different Treatment Methods Applied to Spine in Chronic Non-Spesific Low Back Pain: A Randomized Controlled Trial

We aimed to investigate the effects of instrument assisted manipulation (IAM) and Mulligan mobilization with movement (MWM) on joint range of motion (ROM), pain, proprioception, endurance, back awareness and disability in individuals with chronic non-specific low back pain (CNSLBP). Fifthy one participants were randomly divided into 3 groups. The first was the Mulligan group, the second was the IAM group, and the third was the core exercise group. Visual Analogue Scale (VAS) was used to assess pain severity. Lumbal flexibility was evaluated with the fingertip-to-floor test. Oswestry disability index (ODI) and Roland Morris Disability Questionnaire (RMDQ) used to evaluate the disability. Fremantle back awareness questionnaire (FBAQ) used to evaluate back awareness. Joint ROM (lumbal flexion, lumbal extension and lumbal lateral flexion) and proprioception (30° lumbal flexion in standing, 30° lumbal flexion in sitting, 15° lumbal extension standing and lumbal neutral position) evaluated with JTECH digital dual inclinometer. McGill core endurance tests were used for core endurance assessment. McGill core endurance assessment consists of 3 tests. These: Flexor endurance test, lateral endurance test and extensor endurance test.

Study Overview

Detailed Description

IAM and Mulligan MWM interventions were applied 3 days a week for 2 weeks in total 6 sessions. All 3 groups did same core exercise program. The exercise program was done from the baseline for 6 weeks, 3 days a week, for a total of 18 sessions. Outcome measurements were done at baseline, at the end of the 2nd week, and at the end of the 6th week. The researcher who performed the outcome measurements did not know the participant's group. Assessment and treatment were performed by two different researchers with 8 years of professional experience. Visual Analogue Scale (VAS) was used to assess pain severity. Lumbal flexibility was evaluated with the fingertip-to-floor test. Oswestry disability index (ODI) and Roland Morris Disability Questionnaire (RMDQ) used to evaluate the disability. Fremantle back awareness questionnaire (FBAQ) used to evaluate back awareness. Joint ROM (lumbal flexion, lumbal extension and lumbal lateral flexion) and proprioception (30° lumbal flexion in standing, 30° lumbal flexion in sitting, 15° lumbal extension standing and lumbal neutral position) evaluated with JTECH digital dual inclinometer. The measurement of the joint ROM in the lumbal region with the dual inclinometer technique is a reliable method. McGill core endurance tests were used for core endurance assessment. McGill core endurance assessment consists of 3 tests. These: Flexor endurance test, lateral endurance test and extensor endurance test.

Study Type

Interventional

Enrollment (Actual)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tokat, Turkey, 60250
        • Faculty of Health Sciences, Tokat Gaziosmanpaşa University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • LBP for at least 3 months
  • Diagnosis of non-specific LBP
  • 20-55 ages.

Exclusion Criteria:

  • Red flag symptoms related to LBP
  • Neurological findings
  • Pain radiating to the leg
  • Undergone spinal surgery
  • Pathology of the spine (fracture, tumor, spondylolisthesis, spinal stenosis, cauda equina syndrome).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Instrument Assisted Manipulation Group
Instrument Assisted Manipulation + Core exercises
The effect of Instrument assisted manipulation on chronic non-spesific low back pain
Experimental: Mulligan Mobilization with Movement Group
Mulligan Mobilization with Movement + Core exercises
The effect of Mulligan mobilization with movement on chronic non-spesific low back pain
Active Comparator: Control group
Core exercises
The effect of core exercises on chronic non-spesific low back pain

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline visual analogue scale at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
Pain assessment. The minimum score of the visual analogue scale is 0, and the maximum score is 10. Higher scores indicate worse outcome.
Baseline, 2nd week, 6th week
Change from baseline fingertip-to-floor test at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
Lumbal flexibility
Baseline, 2nd week, 6th week
Change from baseline joint ROM measurement with digital inclinometer at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
Lumbal flexion, lumbal extension and lumbal lateral flexion
Baseline, 2nd week, 6th week
Change from baseline proprioception measurement with digital inclinometer at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
30° lumbal flexion in standing, 30° lumbal flexion in sitting, 15° lumbal extension standing and lumbal neutral position
Baseline, 2nd week, 6th week
Change from baseline Oswestry disability index at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
Disability assessment. The minimum score of the Oswestry disability index is 0, and the maximum score is 50. Higher scores indicate worse outcome.
Baseline, 2nd week, 6th week
Change from baseline Roland Morris disability questionnaire at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
Disability assessment. The minimum score of the Roland Morris disability questionnaire is 0, and the maximum score is 24. Higher scores indicate worse outcome.
Baseline, 2nd week, 6th week
Change from baseline Fremantle back awareness questionnaire at 2nd and 6th weeks
Time Frame: Baseline, 2nd week, 6th week
Back awareness assessment. The minimum score of the Fremantle back awareness questionnaire is 0, and the maximum score is 36. Higher scores indicate worse outcome.
Baseline, 2nd week, 6th week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erkan Erol, PhD, Tokat Gaziosmanpaşa University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2019

Primary Completion (Actual)

February 28, 2020

Study Completion (Actual)

June 30, 2020

Study Registration Dates

First Submitted

November 16, 2022

First Submitted That Met QC Criteria

November 24, 2022

First Posted (Estimate)

December 6, 2022

Study Record Updates

Last Update Posted (Estimate)

December 6, 2022

Last Update Submitted That Met QC Criteria

November 24, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GaziosmanpasaU_Erol_01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Low-back Pain

Clinical Trials on Instrument assisted manipulation + Core exercises

3
Subscribe